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Augmentation of peritoneal dialysis clearance with procaine
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Augmentation of peritoneal dialysis clearance with procaine. Local
anesthetic procaine in a 0.25% concentration was used as the adjunct to
the dialysis fluid during peritoneal dialysis in rabbits. Procaine in-
creased peritoneal clearance of urea (2.213 0.187 mI/mm to 3.544
0.41 mllmin) and inulin (0.528 0.079 mI/mm to 0.852 0.213 mI/mm).
Effect of the drug persisted, despite its lack, during the following
cycles. Procaine influenced transmesothelial transfer of urea and inulin
in vitro. The effect of the drug was biphasic. During the first 20 mm a
decrease of both solutes fluxes was observed. Then the transport rate of
urea and inulin started to grow. The effect of procaine was independent
of the membrane's side to which the drug was added. At least two sites
of procaine action (vascular system and mesothelium) during peritoneal
dialysis are proposed.
Augmentation de Ia clearance de dialyse peritoneale avec Ia procaine.
La procaine, un anesthésique local, a Ia concentration de 0,25% a été
employee comme adjuvant au liquide de dialyse pendant une dialyse
péntonéale chez des lapins. La procaine a augmente Ia clearance
péritonéale de l'urée (de 2,213 0,187 mI/mm a 3,544 + 0,41 ml/min)
et de l'inuline (de 0,528 0,079 mI/mm a 0,852 0,213 mI/mm). L'effet
du médicament a persisté, même en son absence, pendant les cycles
suivants. La procaine a influence Ic transfert transmésothélial de l'urée
et de l'inuline in vitro. L'effet du médicament était biphasique. Pendant
les 20 premieres minutes une diminution du flux des deux solutes était
observe. La vitesse de transport de l'urée et de l'inuline commencait
ensuite a croItre. L'effet de la procaine était independant du cóté de Ia
membrane oü le médicament était ajouté. On propose au moms deux
sites d'action de Ia procaine (système vasculaire et mésothélium)
pendant la dialyse péritonéale.
Peritoneal dialysis is a recognized form of treatment in
patients with renal failure [1, 21. However, its use is not
widespread due to its believed limited efficiency in comparison
with hemodialysis [31. A number of approaches have been made
in an attempt to increase peritoneal dialysis efficiency [4—7].
Recently, data describing the changes of the mesothelial perme-
ability to solutes under the influence of docusate sodium or
protamine have been presented [8, 9].
Local anesthetics can change both the structure and func-
tion of cells and epithelia [10—12]. Precise mechanism of their
action at the molecular level is not known, however, inter-
action with lipids of the cellular membrane or dissociation of
the cytoskeletal elements were suggested [13, 14]. Besides, they
can cause vasodilation of the blood vessels [15, 16]. The
purpose of our study was to find the effect of the local
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anesthetic procaine, used intraperitoneally, on the solute clear-
ances during peritoneal dialysis. To distinguish between the
vascular and mesothelial site of the drug action, we performed
experiments on rabbits in vivo and on the isolated fragments of
the rabbit's mesentery in vitro.
Methods
Experiments in vivo. Peritoneal dialysis was performed in
seven healthy New Zealand white rabbits weighing an average
of 2.2 kg (1.8 to 2.5 kg). The animals were anesthetized with
ketamine (Ketanest, Parke-Davis, Morris Plains, New Jersey),
15 mg/kg of body wt i.m., and Diazepam (Relanium-Poifa), 1
mg/kg of body wt i.m., in preparation for the cannulization of
blood vessels and placement of the dialysis catheter. During the
performance of the peritoneal dialysis, rabbits were sedated
with Diazepam, 0.01 mg/kg body wt/min i.v. The dialysis
catheter was placed in the right lower quadrant of the abdomen.
To avoid leaks peritoneum and abdominal muscles were su-
tured in two layers. Any leak of dialysis fluid or persistent
bleeding excluded the animal from the experimental protocol.
Femoral vein and artery were cannulated. To maintain a
constant blood level of urea and inulin, a primary dose of urea,
10 mg/lOO g body wt, and inulin, 13.75 mg/l00 g body wt, was
followed by a continuous infusion of saline solution containing
urea (20 mg%/lOO g body wt) and inulin (27 mg%/l00 g body wt)
with the rate of 0.48 ml/min.
Peritoneal dialysis was performed with Hanks solution made
hypertonic (370 mOsm) with mannitol. Heparin was added into
the fluid (50 U/dl) to prevent the catheter obstruction by fibrin.
The dialysate exchange volume was 75 mi/kg body wt. Dialysis
fluid was warmed to 37°C and instilled into the peritoneal cavity
within I mm with a syringe. Instantly after the instillation,
samples of diaiysate and arterial blood were taken for urea and
inuiin levei measurements. Dwell-time was 20 mm and after that
time blood and dialysate samples were taken again. Then
dialysate was allowed to drain by gravity; drainage was assisted
by applying light manual massage to the abdomen. Urea con-
centration in samples was estimated by the diacetyi monoxime
method [17]. Absorbance of the colored reaction product was
measured on a spectrophotometer (Spectromom 203-MOM,
Hungary). Inulin concentration was measured by the anthrone
method [18].
In every rabbit dialysis consisted of seven cycles. Three prelimi-
nary cycles were designated control cycles and the following as
experimental. Procaine (Procaine-HC1-Koch Light Labomtory) was
added to the dialysis fluid in cycles 4 and 7 to achieve its final
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concentration of 0.25%. Solute clearances were calculated for each
dialysis exchange according to the equation:
Vd x Cd2 — CdlClearancemjjmjn =
[Cs1 + Cs2
[ 2 _CdI]Xt
where: Cdl and Cd2 represent the concentration of the solute in
the dialysate at the beginning and at the end of the exchange,
respectively; Vd, volume of dialysate recovered; C and C2,
concentration of the solute in serum at the beginning and at the
end of the exchange, respectively; t, dwell-time.
A separate series of experiments was performed during which
no drug was added to the dialysis fluid. The purpose of this
study was to evaluate the changes of the peritoneal permeability
in time.
Experiments in vitro. Studies were performed on the
mesentery of the ileum from the New Zealand white rabbits.
The animals were killed by a blow on the head. Then the
abdomen was opened and the ileal mesentery was isolated. A
procedure was performed to obtain the membrane possessing
only one layer of the mesothelium. The mesentery was dis-
severed by a gentle mechanical preparation in situ (Fig. 1). The
obtained membrane, containing a single layer of the meso-
thelium, was mounted between two semichambers with active
area 1.3 cm2. Chambers were filled with Hanks solution which
was mixed, oxygenated, and buffered with a gas mixture (98%
02 and 2% C02). Inulin and urea were added to the vascular
side of the membrane to obtain the concentration of 50 and 100
mg%, respectively. Every 10 mm samples were taken from both
sides of the membrane. The urea concentration was measured
in the same manner as in in vivo experiments. The transfer of
inulin was evaluated with the use of the isotope tracer (3H-
inulin, Amersham, Arlington Heights, Illinois) added simul-
taneously to the vascular side of the membrane with the cold
substance. Radioactivity of the samples was measured with a
beta counter (LS IOOC Beckman Instruments Inc., Fullerton,
California). Values of urea and inulin transfer were corrected
for the steadily declining concentration gradient between the
vascular and the mesothelial side of the membrane. To assess
the viability of the mesothelial cells, a series of experiments was
performed in which transepithelial transport of urea and inulin
was evaluated for a duration of 100 mm.
During experiments with procaine every membrane studied
served as its own control. Control fluxes were measured for 30
mm. After that time procaine was added either to the
mesothelial or the vascular side of the membrane in an amount
sufficient to obtain the final concentration in the 0.25% medium.
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Fig. 1. The preparation of the meseneery to obtain a single layer of the
mesothelium.
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Fig. 3. Mean values SE ofperitoneal clearance of urea during dialysis
performed with procaine.
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Then the effect of the drug on the transmesothelial transport of
the studied solutes was observed for 50 mm.
Results were expressed as mean SE. Student's t test for
paired data was used. A P value of less than 0.05 was consid-
ered significant.
Results
Experiments in vivo. During control experiments performed
without the anesthetic, the values of the peritoneal clearances
of urea and inulin did not change significantly in time (Fig. 2).
In procaine experiments mean values of urea and inulin
peritoneal clearances during three preliminary dialysate ex-
changes were 2.213 0.187 and 0.529 0.079 mi/mm, respec-
tively. Procaine added to the dialysis fluid increased the clear-
ance of urea by 25% on the average (P < 0.01). The effect
persisted during the next cycle, which was performed without
an anesthetic, because the urea clearance was higher by 53% in
reference to the control (P < 0.01). After that time the effect of
procaine on the urea peritoneal removal diminished; in cycle 6,
in which dialysis fluid was still without procaine, urea clearance
was higher than in control cycles by only 22% (P < 0.05).
Application of the drug during the next cycle again caused an
increase of the urea peritoneal clearance (Fig. 3).
Procaine added intraperitoneally also augmented the removal
of inulin via peritoneum. The increase was instant, however,
the effect was slower and prolonged (Fig. 4). The maximal effect
was observed in cycle 6 in which inulin clearance was higher by
54% in reference to the control period (P < 0.05). Average
values SE of urea and inulin peritoneal clearances in all cycles
are listed in Table 1.
Experiments in vitro. We conducted a separate series of
control experiments without any drug and did not observe
significant changes of the transmesothelial transport of urea and
inulin (Fig. 5).
Procaine applied either to the mesothelial or to the vascular
side of the membrane affected permeability of the mesothelium
similarly. Initially, a decrease of both fluxes was observed.
However, after 20 mm the transport rate of urea and inulin
began to rise (Fig. 6). Mean values SE of urea and inulin
transfer in every period studied are presented in Table 2.
Transmesothelial transport of urea was in each case more
inhibited during the first phase of the drug's action, than during
that of inulin. However, in the second phase of the drug's
action, the maximal increase of the transepithelial transfer of
inulin was higher than the respective measure for urea.
Discussion
Based upon the results obtained we conclude that local
anesthetic procaine in a concentration of 250 mg/dl of the
dialysis fluid does increase the peritoneal clearance of urea and
inulin. The effect is instant and retentive. It results from the in
vivo as well as from the in vitro studies, which showed that
peritoneal clearances and flux rates across the membrane rose
constantly after the drug was added to the bathing fluid.
There may be at least two sites of procaine action during
peritoneal dialysis. Procaine presumably increases blood flow
into the peritoneal microcirculation either by the blockade of
the autonomic nerve fibers or due to its direct vasodilating
action [15, 16]. However, another mechanism of action, that is,
the increase of the mesothelial permeability, should also be
considered.
During the first exchange performed with the anesthetic, the
enhancement of urea and inulin peritoneal clearances was
roughly the same (25 and 23%, respectively). In the subsequent
fluid exchange, performed without procaine, urea clearance
was increased by 54% in reference to control whereas inulin
clearance was increased by only 25%. This discrepancy may be
interpreted as an increase of the total membrane area available
for diffusion which may be due to the vasodilation. During the
next exchange, which was performed also without the anes-
4 5 6 7
E
C
C
U)0C
U)
U)
U)
C-)
Cycle number
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Table 1. Average peritoneal urea and inulin clearances SE during dialysis performed with procaine
Clearance of
substance studied
Cycle
1 2 3 4
Procaine
5 6 7
Procaine
Clearanceurea, mI/mm 2.168 2.150 2.32 2.903
P < 0.01
+25%
3.544
P < 0.01
+53%
2.835
P < 0.05
+ 22%
3.343
P < 0.01
+ 44%
Clearance1011, mI/mm 0.519 0.512 0.553 0.682
P < 0.02
+23%
0.694
P < 0.05
+25%
0.852
P < 0.05
+54%
0.943
P < 0.05
+71%
thetic, the relations were inverse; peritoneal clearance of inulin
was more augmented than the respective measure for urea.
Therefore, we interpreted that as an increase of the mean pore
radius in the membrane. We postulate that procaine given
intraperitoneally acts through two main mechanisms: vaso-
dilation with the subsequent increase of the membrane's perme-
ability due to the enlarged mean pore radius in the mesothelium.
A similar magnitude of enhancement of the peritoneal clear-
ances of urea and inulin during the first fluid exchange with
procaine, despite the vasodilation, may be explained by a
simultaneous decrease of the membrane's permeability to both
solutes. During experiments in vitro it was more marked for
urea and a similar effect may be expected in vivo. Therefore, an
increase of the urea removal via the peritoneum due to vasodila-
tion may be reduced by a concomitant decrease of the
mesothelial permeability to this solute.
It is difficult to precisely define the nature of changes induced
by procaine in the function of the mesothelium. It is postulated
that local anesthetics interact with lipids of the cell membrane
and with the cytoskeleton as well [13, 14]. Nicolson, Smith, and
Poste [10] found that local anesthetics added to the culture of
the endotheljojd cells BALB/3T3 caused alterations in cell
shape and cytoskeleton organization within 15 to 30 mm. Local
anesthetics disrupt microtubules and microfilaments; their ac-
tion can be duplicated by treatment of the cells with colchicine
or vinbiastine together with cytochalasin B [14]. There is some
evidence that the tight-junction permeability depends on the
cytoskeletal function [19]. Inulin is supposed to cross the
mesothelium through the paracellular pathway. During in vitro
experiments we observed a greater, procaine-induced, increase
of the inulin transepithelial transfer in comparison with urea.
Therefore, we speculate that this effect was due to the increase
of the paracellular pathway permeability.
We suppose that procaine also affects the permeability of the
transcellular pathway, which could explain the greater decrease
of the urea transfer in comparison with inulin during a prelimi-
nary 20-mm period in in vitro experiments. Urea is believed to
cross the mesothelium also through the transcellular pathway
and perhaps a procaine-induced decrease of its permeability
could be responsible for the observed discrepancies. This effect
may be transient or it may be overshadowed by later changes in
the paracellular pathway.
We cannot say ultimately on which side of the mesothelium
procaine acts. During in vitro experiments, changes of the
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Table 2. Mean values SE of the transmesothelial transfer rate of urea and inulin during in vitro experiments with procaine
Membrane's side
of procaine
action d substance
Time, mm
Studie 10 20 30 40 50 60 70 80
N= 9
Vascular Tura
nmoles X cm2 X s'
2.911 2.825 2.934 2.268
P < 0.01
—23%
2.759
NS
—6%
3.189
NS
+9%
3.532
NS
+20%
3.850
P < 0.05
+32%
Mesothelial
N= 8
Turea
nmoles X cm2 x s
2.313 2.439 2.372 1.754
P < 0.01
—26%
2.067
NS
—13%
2.422
NS
+2%
3.048
P < 0.01
+28%
3.168
P < 0.01
+34%
Vascular
N=9
T10011,,pmoles x cm2 x s
7.191 7.379 7.533 6.182
P < 0.02
—18%
8.028
NS
—7%
9.209
NS
22%
9.703
P < 0.05
+29%
10.680
P < 0.01
+42%
Mesothelial
N= 8
T,,01,.pmoles x cm x s
5.275 5.023 5.210 4.245
P < 0.05
—19%
4.972
NS
—5%
5.681
NS
+9%
6.360
NS
+22%
7.202
P < 0.05
+38%
mesothelial permeability evoked by the anesthetic were instan-
taneous, independently on the side of the membrane on which
the drug was applied. Therefore, we speculate further that the
interaction of the drug with the basement or apical cell's
membrane may cause subsequent, similar changes in the func-
tion of the cytoskeletal system.
It is difficult to foresee, whether or not a local anesthetic may
become useful during peritoneal dialysis in humans. But it
seems that their action may be advantageous as the adjunct to
the dialysis fluid, inducing a slight anesthesia of the peritoneal
cavity, and providing patients with a higher level of comfort.
Reprint requests to Dr. A. Brçhorowicz, Department of Patho-
physiology, Medical Academy, ul. Swifcickiego 6, 60-781 Poznad,
Poland
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